These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 17613611

  • 1. The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis.
    Kezele IB, Chen JT, Arnold DL, Collins DL.
    Mult Scler; 2007 Jul; 13(6):809-13. PubMed ID: 17613611
    [Abstract] [Full Text] [Related]

  • 2. Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions.
    Kezele IB, Arnold DL, Collins DL.
    Mult Scler; 2008 Jul; 14(6):779-85. PubMed ID: 18611990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 5. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
    Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL.
    J Neurol Sci; 2009 Jul 15; 282(1-2):72-9. PubMed ID: 19232641
    [Abstract] [Full Text] [Related]

  • 6. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 15; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Bernardi V, Favaretto A, Barachino L, Romualdi C, Rinaldi L, Perini P, Gallo P, Filippi M.
    Neurology; 2009 Apr 14; 72(15):1330-6. PubMed ID: 19365054
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion.
    Chen JT, Kuhlmann T, Jansen GH, Collins DL, Atkins HL, Freedman MS, O'Connor PW, Arnold DL, Canadian MS/BMT Study Group.
    Neuroimage; 2007 Jul 15; 36(4):1152-8. PubMed ID: 17543541
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis.
    van Walderveen MA, van Schijndel RA, Pouwels PJ, Polman CH, Barkhof F.
    J Magn Reson Imaging; 2003 Dec 15; 18(6):656-64. PubMed ID: 14635150
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb 15; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ.
    Neuroimage; 2009 Mar 01; 45(1):60-7. PubMed ID: 19013533
    [Abstract] [Full Text] [Related]

  • 18. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep 01; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
    Masek M, Vaneckova M, Krasensky J, Danes J, Havrdova E, Hrebikova T, Seidl Z.
    Neuro Endocrinol Lett; 2008 Aug 01; 29(4):461-6. PubMed ID: 18766142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.